#oncology #Imfinzi #durvalumab #AstraZeneca #NICErecommendation #lungcancer #lungcancerpatients #lungcancertreatment #resectablenonsmallcelllungcancer #NSCLC #AEGEANphase3trial #NHS #NSCLCpatients #ThoracicOncology #patientoutcomes #AEGEANtrial
pharmatimes.com/news/imfinzi...
0
0
0
0